Status:
COMPLETED
Hereditary Paraganglioma: Evaluation of Screening Methods to Detect Tumors in SDH Positive Carriers
Lead Sponsor:
University Hospital, Angers
Collaborating Sponsors:
Assistance Publique - Hôpitaux de Paris
Conditions:
Paraganglioma
Pheochromocytoma
Eligibility:
All Genders
6+ years
Phase:
NA
Brief Summary
Hereditary paraganglioma -due to SDH (SDHD, SDHB, SDHC) germline mutations- causes paragangliomas and pheochromocytomas. Presymptomatic genetic testing should be offered to all first-degree relatives ...
Eligibility Criteria
Inclusion
- Inclusion Criteria: identification of an SDH (SDHD, SDHD, SDHC) germline mutation
Exclusion
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2013
Estimated Enrollment :
248 Patients enrolled
Trial Details
Trial ID
NCT00188019
Start Date
November 1 2005
End Date
November 1 2013
Last Update
July 23 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Européen Georges Pompidou Hospital
Paris, France, 75015